Taastumine ja paranemine.
Regeneratsioonisektsioon: BPC-157, TB-500, mõlemad ühes pennis, lisaks KPV, ARA-290, cartalax ja thymalin. Lugege tõendite lehti enne tellimist — loomkatsete kirjandus on siin mahukas ja inimuuringute kirjandus on õhuke, ning mõlemad faktid kuuluvad samale lehele.
DEAL −15%
DEAL −15%
DEAL −15%
DEAL −15%
DEAL −15%
DEAL −15%
DEAL −15%Enne tellimist
BioregulatorsCartalax and Chonluten: the bioregulators with almost no published record
Same Khavinson school as Thymalin and Epithalon, a fraction of the evidence. One cell-culture study for Chonluten, no readable efficacy study at all for Cartalax — and that asymmetry is the article.
LongevityEpithalon and the telomere claim: what the Khavinson papers actually report
Telomerase reactivation in a dish, extra passages past the Hayflick limit, longer-lived flies and mice — and no modern human trial. The published Epithalon record, figure by figure.
RepairARA-290 (cibinetide): four human trials, and the endpoints they missed
This is one of the very few compounds on the repair shelf with real randomised human data — four published trials, including a 64-subject phase 2b. Read them closely and the nerve-regeneration endpoint separates from placebo while the pain endpoint mostly does not.